Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

PATTI, Angelo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.974
EU - Europa 2.344
AS - Asia 898
SA - Sud America 163
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 7.426
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.953
IT - Italia 1.144
SG - Singapore 365
CN - Cina 341
FI - Finlandia 300
DE - Germania 276
UA - Ucraina 141
BR - Brasile 132
GB - Regno Unito 99
IE - Irlanda 99
RU - Federazione Russa 55
SE - Svezia 53
FR - Francia 36
RO - Romania 32
IN - India 31
IR - Iran 27
HK - Hong Kong 23
BE - Belgio 22
AT - Austria 20
CI - Costa d'Avorio 20
KR - Corea 18
TR - Turchia 15
ES - Italia 11
NL - Olanda 10
UZ - Uzbekistan 10
CA - Canada 9
CH - Svizzera 8
MX - Messico 8
MY - Malesia 8
GR - Grecia 7
IL - Israele 7
PK - Pakistan 7
AR - Argentina 6
IQ - Iraq 6
PH - Filippine 6
PL - Polonia 6
DK - Danimarca 5
SA - Arabia Saudita 5
BO - Bolivia 4
CL - Cile 4
CO - Colombia 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EU - Europa 4
ID - Indonesia 4
MA - Marocco 4
UY - Uruguay 4
VE - Venezuela 4
AU - Australia 3
BD - Bangladesh 3
BG - Bulgaria 3
KE - Kenya 3
LB - Libano 3
NP - Nepal 3
TW - Taiwan 3
VN - Vietnam 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
EC - Ecuador 2
EG - Egitto 2
ET - Etiopia 2
HU - Ungheria 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BT - Bhutan 1
BY - Bielorussia 1
CR - Costa Rica 1
GE - Georgia 1
HN - Honduras 1
HT - Haiti 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
LU - Lussemburgo 1
ME - Montenegro 1
NO - Norvegia 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SM - San Marino 1
TN - Tunisia 1
Totale 7.426
Salva come PNG Salva come JPEG
Città #
Fairfield 556
Chandler 406
Ashburn 332
Singapore 263
Wilmington 254
Woodbridge 251
Seattle 216
Houston 210
Cambridge 182
Ann Arbor 164
Palermo 129
Medford 108
Des Moines 104
Dublin 98
Jacksonville 77
Rome 72
Princeton 68
Altamura 67
Nanjing 67
Milan 61
Lawrence 51
Santa Clara 44
New York 41
San Diego 37
Boardman 32
Jinan 30
Tulsa 26
Dearborn 25
Shenyang 23
Beijing 22
Nanchang 22
Changsha 21
Abidjan 20
Brussels 19
Hebei 19
Tianjin 19
Redwood City 18
London 17
Ningbo 17
Nuremberg 17
Ludwigshafen am Rhein 16
Tehran 16
Hong Kong 14
Florence 13
The Dalles 13
Helsinki 12
Naples 12
São Paulo 12
Verona 12
Bari 11
Munich 11
Napoli 11
San Paolo di Civitate 11
Columbus 10
Falls Church 10
Jiaxing 10
Cagliari 9
Chicago 9
Kumar 9
Pisa 9
Seongnam 9
Venice 9
Amsterdam 8
Bangalore 8
Catania 8
Council Bluffs 8
Edinburgh 8
Guidizzolo 8
Los Angeles 8
Saint Petersburg 8
Auburn Hills 7
Central 7
Dallas 7
Guangzhou 7
Haikou 7
Lappeenranta 7
Padova 7
Pune 7
Taizhou 7
Zhengzhou 7
Genoa 6
Gwangmyeong 6
Izmir 6
Lanzhou 6
Moscow 6
Phoenix 6
Piscataway 6
Rio de Janeiro 6
Vienna 6
Azor 5
Castrovillari 5
Turin 5
Washington 5
Avola 4
Baghdad 4
Belo Horizonte 4
Bologna 4
Brescia 4
Hangzhou 4
Kuala Lumpur 4
Totale 4.689
Salva come PNG Salva come JPEG
Nome #
PROBIOTICI E TERAPIA CONVENZIONALE: NUOVE FRONTIERE NELLA GESTIONE DELLE MANIFESTAZIONI ARTICOLARI DELLE MALATTIE INFIAMMATORIE INTESTINALI (IBD) 763
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 205
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 175
Osteodystrophy in chronic liver diseases. 163
Management of Statin Intolerance in 2018: Still More Questions Than Answers 162
The Role of Nutraceuticals in Statin Intolerant Patients 156
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 155
The effect of bergamot on dyslipidemia 155
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 153
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 150
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 147
Autoimmune liver disease in a sicilian woman. 145
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. 137
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 135
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 134
O- Alkylation of a lignite humic acid by phase-transfer catalysis 128
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 124
Lichen sclerosus as a cause of recurrent cystitis: case report and review of the literatury. 121
REPORT OF A CASE OF MALIGNANT TUMOR-LIKE GASTRIC LESION BY CANDIDA IN A DIABETIC TREATED WITH CYCLOSPORINE FOR PSORIASIS AND REVIEW OF THE LITERATURE 119
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 119
Diagnostica non invasiva delle varici esofagee nei pazienti con cirrosi epatica: dati ecografici vs dati endoscopici 117
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes 117
Cloni di carciofo "Romanesco" in coltura annuale in Sicilia 116
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 114
MALIGNANT TUMOR-LIKE GAASTRIC LESION DUE TO CANDIDA ALBICANS IN A DIABETIC PATIENT TREATED WITH CYCLOSPORIN: A CASE REPORT AND REVIEW OF THE LITERATURE 107
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 107
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 107
Cilostazol and atherogenic dyslipidemia: a clinically relevant effect 105
Malignant tumor-like gastric lesion by Candida albicans. 102
Smoking and small, dense low-density lipoproteins. 101
Improving diagnostic accuracy in Celiac Disease diagnosis: anti-endomysium antibody assay in colture medium of duodenal biopsies. 100
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 98
Food hypersensitivity in patients with irritable bowel syndrome: the diagnostic role of fecal assays. 97
INCRETIN-BASED THERAPIES, GLUCOMETABOLIC HEALTH AND ENDOVASCULAR INFLAMMATION 97
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 97
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms 97
Anti-atherogenic Effects of 17β-Estradiol 92
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 90
Nutraceuticals as an important part of combination therapy in dyslipidaemia 90
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes 88
Improving diagnostic accuracy in celiac disease diagnosis: antiendomysium antibody assay in the culture medium of duodenal biopsies. 87
Variazioni emodinamiche del circolo epatico in pazienti con bright liver ecopattern e sindrome metabolica 86
Food hypersensitivity-associated irritable bowel syndrome: may fecal assays improve diagnosis? 86
Effects of Liraglutide on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with The Metabolic Syndrome: A 12-Month Prospective Pilot Study 86
Advances in pharmacological treatment of type 1 diabetes during pregnancy 85
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study 84
Metabolic disorders during pregnancy and postpartum cardiometabolic risk 83
Prevalence of antibodies anti-bartonella henselae in western Sicily: children, blood donors, cats 82
Rare Candida albicans overgrowth in an immunosuppressed patient: case report of a malignant tumor-like gastric lesion. 79
Serological, immunomorphological and bioinformatics analyses suggest Hsp60 is involved in Hashimoto’s thyroiditis pathogenesis. 77
Future perspectives of the pharmacological management of diabetic dyslipidemia 77
Lichen sclerosus and atrophicus: report of a case of female patient affected with recurrent cystitis. 77
Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study 75
Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. 71
Natural approaches in metabolic syndrome management 71
Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases 68
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 66
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. 66
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. 63
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan 63
Pharmacotherapy for gestational diabetes 63
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? 61
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. 56
PREVALENCE OF LIVER STEATOSIS AND FIBROSIS AND RELIABILITY OF ULTRASOUND IN DETECTING NAFLD IN OBESE PATIENTS 54
Oxidative stress and small, dense low-density lipoproteins: Current and future perspectives 52
Novel therapeutical approaches to managing atherosclerotic risk 51
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes 39
NUOVE STRATEGIE PER IL MANAGEMENT CLINICO, DIAGNOSTICO E TERAPEUTICO DELLE MALATTIE CARDIO-METABOLICHE 37
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus 35
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 35
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 34
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes 31
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes 28
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies 26
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update 22
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes 19
Obesity and HFpEF 18
Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome 17
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance 16
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review. 14
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? 14
Impact of different hormones on the regulation of nitric oxide in diabetes 10
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies 8
Totale 7.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.646
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020231 0 0 0 0 0 0 0 0 0 56 140 35
2020/20211.196 25 63 106 243 171 42 62 90 109 130 68 87
2021/2022881 51 136 40 32 23 38 35 76 92 140 66 152
2022/20231.411 135 211 30 135 126 191 126 120 151 37 91 58
2023/2024681 35 91 53 43 44 143 85 37 20 18 34 78
2024/20251.053 29 172 113 143 67 55 116 80 116 162 0 0
Totale 7.857